DALLAS, April 20, 2017 /PRNewswire/ — Puration, Inc. (USOTC: PURA) and ML Capital Group, Inc. (USOTC: MLCG) today announced reaching a major milestone in their partnership through Spanish Peaks ScrumpDelicacies to introduce a cannabis tourism offering in Colorado’s $19 billion tourism industry.  PURA and MLCG struck an agreement in February where both companies are to contribute to an equity purchase of Spanish Peaks ScrumpDelicacies. The funds from the equity purchase are to go to the construction of a Spanish Peaks cannabis beverage production facility.  PURA will provide cannabis extract through their patented extraction process for the Spanish Peaks beverages and MLCG will conduct Napa Valley like cannabis tours in Colorado that feature a state of the art Spanish Peaks facility.  Both PURA and MLCG plan to distribute a portion of the stock acquired from Spanish Peaks to their respective shareholders through dividend distributions.  The major milestone announced today in conjunction with the national 420 celebration is that Spanish Peaks is merging with a publicly traded company and the dividend distributions of Spanish Peaks stock to PURA and MLCG shareholders will be a publicly traded Spanish Peaks stock.  Both the equity purchase of Spanish Peaks by PURA and MLCG, and the public company merger of Spanish Peaks are anticipated to be complete by the end of May.

Learn More About Puration: http://www.purationinc.com

Learn More About ML Capital: http://www.buymlcg.com

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.